Abstract
Background Erdafitinib is a pan-fibroblast growth factor receptor (FGFR) inhibitor approved for the treatment of locally advanced or metastatic urothe......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
